Wikipedia -WSS

Wikipedia

author：knowledge 2025-10-01 18:34:29 - browse：9

Johnson & Johnson sign — MARK RALSTON/AFP via Getty Images

WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the Biden administration over its new Medicare drug price negotiation program.

J&J joins a flurry of litigation challenging the Medicare drug price negotiation program, which is set to start this fall. Merck, Bristol Myers Squibb, the brand-drug lobby PhRMA, and the U.S. Chamber of Commerce have also filed suit. The negotiated prices would go into effect in 2026.

The company argued that it is entitled to sue because its blockbuster blood thinner drug Xarelto may be up for negotiation in the first round of ten drugs Medicare will examine, but that list is not set to be announced officially until Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： EPA limits use of carcinogenic gas for sterilizing medical devices

WSS

Medicare coverage of Wegovy, once blocked, now looks possible

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

HHS secretary Becerra pressed on Change HealthCare cyberattack

Long Covid research funding gets a major boost from NIH

Too many hospitalized Covid

Readout Newsletter: CAR

hotspot

Wikipedia

knowledge

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

How to save PrEP access — and even expand it

Readout Newsletter: CAR

Trump demands the U.S. pay no more for drugs than other countries … again

Having children helps parents live longer, especially after age 80

Wildfire smoke exposes gaps in outdoor worker protections

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Medical records are filled with copy

Congress might make insulin pumps more accessible to the blind

hotspot

Steward Health Care Massachusetts hospitals face fiscal disaster

Change Healthcare outage fallout shows need for new oversight

Resistance to opioid

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Congress might make insulin pumps more accessible to the blind

Boston's new lab space is opening empty

focus

knowledge

focus

focus